MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ
404.24
+6.72
+1.69%
After Hours: 404.24 0 0.00% 16:20 03/01 EST
OPEN
397.52
PREV CLOSE
397.52
HIGH
404.88
LOW
394.13
VOLUME
332.82K
TURNOVER
0
52 WEEK HIGH
407.41
52 WEEK LOW
167.00
MARKET CAP
12.43B
P/E (TTM)
45.54
1D
5D
1M
3M
1Y
5Y
RiverPark/Next Century Growth Fund Q4 2023 Investor Letter
RiverPark/Next Century Growth Fund returned 4.75% in the fourth quarter of 2023 vs. The total return of the Russell 2000 Growth Index of 12.75%. The Fund is monitoring potential growth headwinds in this choppy macro environment. Investor sentiment continues to swing wildly. The Fund continues to invest in the fastest growing companies in America.
Seeking Alpha · 2d ago
Should Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) Be on Your Investing Radar?
NASDAQ · 3d ago
Weekly Report: what happened at MEDP last week (0219-0223)?
Weekly Report · 6d ago
Have Medpace Holdings Insiders Been Selling Stock?
August Troendle, the Chairman & CEO of Medpace Holdings, Inc. Recently sold shares for US$25m. The average price of shares is below the current price of US$402. In the last year Medpace Holding insiders haven't bought any stock. But the company does have a high insider ownership of 21% of the company. It is good to see that Medspace Holdings is growing earnings. But there were no insider purchases in the last 12 months.
Simply Wall St · 02/24 13:50
$1000 Invested In Medpace Hldgs 5 Years Ago Would Be Worth This Much Today
Medpace Hldgs has outperformed the market over the past 5 years by 35.96%. The company has an average annual return of 48.67%. If an investor bought $1000 of MEDP stock 5 years ago, it would be worth $5,669.52 today.
Benzinga · 02/23 21:00
Zacks.com featured highlights Trip.com, Medpace, Centrus Energy, Suzano and NVIDIA
NASDAQ · 02/23 09:13
Polen U.S. SMID Company Growth Q4 2023 Portfolio Manager Commentary
Seeking Alpha · 02/23 01:22
Weekly Report: what happened at MEDP last week (0212-0216)?
Weekly Report · 02/19 09:16
More
About MEDP
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.

Webull offers Medpace Holdings Inc stock information, including NASDAQ: MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.